US Stock MarketDetailed Quotes
AZN AstraZeneca
- 67.200
- +0.840+1.27%
Close Nov 27 16:00 ET
- 67.225
- +0.025+0.04%
Post 17:32 ET
208.36BMarket Cap32.39P/E (TTM)
67.320High66.550Low4.99MVolume66.690Open66.360Pre Close334.13MTurnover0.16%Turnover Ratio35.28P/E (Static)3.10BShares87.67552wk High5.12P/B207.62BFloat Cap59.19052wk Low1.49Dividend TTM3.09BShs Float87.675Historical High2.21%Div YieldTTM1.16%Amplitude5.373Historical Low67.014Avg Price1Lot Size
AstraZeneca Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | ||||||||||
| Net income from continuing operations | 10.65%1.83B | 14.80%2.4B | 23.78%2.8B | 175.85%6.9B | 15.30%897M | 78.98%1.65B | 745.34%2.09B | 309.04%2.26B | 1,043.77%2.5B | 222.33%778M |
| Other non cash items | 220.23%839M | 73.76%702M | -150.70%-356M | 127.07%1.45B | 142.04%927M | 58.79%262M | 308.08%404M | -1,675.00%-142M | -52.38%639M | -49.41%383M |
| Change In working capital | -95.43%41M | 86.96%-129M | -288.02%-455M | -92.01%300M | -49.83%150M | -15.93%897M | -268.48%-989M | -86.59%242M | 85.90%3.76B | 811.90%299M |
| -Change in receivables | ---- | ---- | ---- | -5.63%-1.43B | ---- | ---- | ---- | ---- | -40.37%-1.35B | ---- |
| -Change in inventory | ---- | ---- | ---- | -116.98%-669M | ---- | ---- | ---- | ---- | 149.90%3.94B | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 8.64%3.38B | 79.57%3.09B | -20.65%2.49B | 5.48%10.35B | -0.75%2.38B | 6.28%3.11B | 37.66%1.72B | -3.06%3.13B | 64.48%9.81B | 69.11%2.4B |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | ||||||||||
| Net PPE purchase and sale | -32.80%-417M | -42.01%-382M | -198.36%-364M | -51.92%-1.23B | -389.72%-524M | -36.52%-314M | -6.32%-269M | 44.29%-122M | 24.95%-809M | 66.56%-107M |
| Net intangibles purchase and sale | -62.32%-909M | -51.32%-286M | -16.06%-1.11B | -105.81%-2.13B | -136.16%-418M | 35.19%-560M | 18.88%-189M | -497.93%-959M | -97.89%-1.03B | 54.85%-177M |
| Net business purchase and sale | -2.93%-281M | -1,221.74%-2.43B | -120.66%-940M | -11.12%-1.18B | -56.61%-296M | 20.18%-273M | 36.11%-184M | -76.03%-426M | 88.75%-1.06B | 13.30%-189M |
| Net investment purchase and sale | 111.04%18M | 109.09%115M | -568.42%-89M | 94.02%-7M | -56.84%82M | 49.54%-163M | 266.67%55M | -61.22%19M | -48.10%-117M | 2,211.11%190M |
| Net other investing changes | ---- | ---- | ---- | --190M | --0 | --15M | --0 | --175M | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -24.00%-1.51B | -452.31%-2.87B | -93.66%-2.41B | -37.30%-4.06B | -332.53%-1.08B | 29.95%-1.22B | 35.00%-520M | -641.67%-1.25B | 73.23%-2.96B | 72.73%-249M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | ||||||||||
| Net issuance payments of debt | -100.08%-2.42B | 21.20%-1.13B | 211.10%5.97B | 19.38%-965M | 24.84%-236M | -2,184.48%-1.21B | -16.24%-1.44B | 546.13%1.92B | -115.16%-1.2B | 63.19%-314M |
| Net common stock issuance | -2,025.00%-77M | 25.00%5M | 50.00%6M | 13.79%33M | 16.67%21M | 33.33%4M | 33.33%4M | -20.00%4M | 0.00%29M | -5.26%18M |
| Cash dividends paid | -11.77%-1.58B | 22.73%-17M | 0.46%-3.03B | -2.68%-4.48B | ---2M | -1.22%-1.41B | ---22M | -2.56%-3.05B | -13.17%-4.36B | --0 |
| Net other financing activities | 152.17%24M | --0 | -0.12%-841M | 15.38%-886M | --0 | 8.00%-46M | --0 | 15.75%-840M | -488.20%-1.05B | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -51.54%-4.13B | 19.55%-1.22B | 199.85%2.03B | 3.75%-6.57B | 18.72%-291M | -90.63%-2.73B | -17.30%-1.52B | 45.70%-2.03B | -286.98%-6.82B | 65.94%-358M |
| Net cash flow | ||||||||||
| Beginning cash position | 22.04%6.68B | 31.98%7.69B | -5.78%5.64B | -0.91%5.98B | 10.34%4.62B | 22.12%5.47B | 8.87%5.83B | -0.91%5.98B | -19.98%6.04B | -36.32%4.19B |
| Current changes in cash | -171.55%-2.26B | -214.33%-1.01B | 1,559.03%2.1B | -1,244.00%-286M | -43.50%1.01B | -242.80%-833M | 62.10%-321M | 78.70%-144M | 101.73%25M | 428.02%1.79B |
| Effect of exchange rate changes | 205.26%20M | 83.33%-6M | -318.18%-46M | 25.00%-60M | 0.00%6M | 62.75%-19M | -38.46%-36M | -22.22%-11M | -29.03%-80M | -45.45%6M |
| End cash Position | -3.98%4.44B | 22.04%6.68B | 31.98%7.69B | -5.78%5.64B | -5.78%5.64B | 10.34%4.62B | 22.12%5.47B | 8.87%5.83B | -0.91%5.98B | -0.91%5.98B |
| Free cash flow | -9.40%2.03B | 95.71%2.42B | -47.02%881M | -9.26%6.57B | -22.23%1.43B | 22.87%2.24B | 75.18%1.24B | -42.04%1.66B | 92.32%7.24B | 163.43%1.84B |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
